Nicolaas I.l.j. Bohnen
#164,067
Most Influential Person Now
Nicolaas I.l.j. Bohnen's AcademicInfluence.com Rankings
Nicolaas I.l.j. Bohnenmedical Degrees
Medical
#3354
World Rank
#3822
Historical Rank
Neurology
#307
World Rank
#390
Historical Rank
Nicolaas I.l.j. Bohnenphilosophy Degrees
Philosophy
#9579
World Rank
#13160
Historical Rank
Logic
#6552
World Rank
#8077
Historical Rank
Download Badge
Medical Philosophy
Nicolaas I.l.j. Bohnen's Degrees
- Doctorate Medicine University of Amsterdam
- PhD Neurology University of Amsterdam
Why Is Nicolaas I.l.j. Bohnen Influential?
(Suggest an Edit or Addition)Nicolaas I.l.j. Bohnen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. (2003) (513)
- Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus (1998) (484)
- The cholinergic system and Parkinson disease (2011) (438)
- Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association (2013) (364)
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association (2013) (362)
- History of falls in Parkinson disease is associated with reduced cholinergic activity (2009) (354)
- Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia (2006) (315)
- Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease (2010) (267)
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature (2012) (255)
- Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease (2006) (237)
- SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* (2012) (207)
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease (2012) (204)
- Cholinergic Dysfunction in Parkinson’s Disease (2013) (201)
- Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study (2011) (193)
- Brain PET in suspected dementia: patterns of altered FDG metabolism. (2014) (181)
- White matter lesions in Parkinson disease (2011) (177)
- Neuropsychological deficits in patients with persistent symptoms six months after mild head injury. (1992) (175)
- Altered Resting State Cortico-Striatal Connectivity in Mild to Moderate Stage Parkinson's Disease (2010) (173)
- Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease (2005) (162)
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review (2015) (157)
- Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia (2012) (155)
- Increased ventral striatal monoaminergic innervation in Tourette syndrome (2003) (149)
- Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education (2013) (148)
- Coping style, trait anxiety and cortisol reactivity during mental stress. (1991) (144)
- Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia (1999) (139)
- Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. (1994) (137)
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. (2013) (136)
- SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 (2016) (135)
- Alzheimer's Disease and Cumulative Exposure to Anesthesia: A Case‐Control Study (1994) (135)
- Dopamine overdose hypothesis: Evidence and clinical implications (2013) (132)
- Neurobehavioral Aspects of Postconcussive Symptoms after Mild Head Injury (1992) (123)
- Modification of the stroop color word test improves differentiation between patients with mild head injury and matched controls. (1992) (119)
- Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease (2007) (117)
- Post-traumatic and emotional symptoms in different subgroups of patients with mild head injury. (1992) (114)
- Spared Caudal Brainstem SERT Binding in Early Parkinson's Disease (2008) (112)
- Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. (2015) (111)
- Performance in the Stroop color word test in relationship to the persistence of symptoms following mild head injury (1992) (110)
- Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease (2018) (108)
- Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease (2005) (105)
- In Vivo Imaging of Human Cholinergic Nerve Terminals with (–)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses (2014) (104)
- Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. (2011) (99)
- Gait speed in Parkinson disease correlates with cholinergic degeneration (2013) (96)
- Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study (2014) (95)
- Cortical cholinergic denervation is associated with depressive symptoms in Parkinson’s disease and parkinsonian dementia (2007) (94)
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 (2020) (93)
- Cholinergic system changes of falls and freezing of gait in Parkinson's disease (2019) (92)
- Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia (2012) (92)
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease. (2013) (90)
- Cortisol reactivity and cognitive performance in a continuous mental task paradigm (1990) (90)
- Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity (2008) (88)
- Neuroimaging of Freezing of Gait (2015) (87)
- Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease. (2010) (85)
- Decreased striatal monoaminergic terminals in Huntington disease (2000) (84)
- Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders (2012) (83)
- Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers (2017) (82)
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia (2013) (80)
- Imaging: What can it tell us about parkinsonian gait? (2013) (77)
- Freezing of gait: understanding the complexity of an enigmatic phenomenon. (2019) (75)
- Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. (2013) (74)
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. (2014) (73)
- Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease (2014) (69)
- Postural control, gait, and dopamine functions in parkinsonian movement disorders. (2006) (68)
- Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education (2013) (67)
- Late neurobehavioural symptoms after mild head injury. (1995) (67)
- Cholinergic denervation occurs early in Parkinson disease (2009) (66)
- Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study (2015) (66)
- Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome (1999) (66)
- Late outcome of mild head injury: results from a controlled postal survey. (1994) (65)
- Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. (2014) (65)
- L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study (2012) (64)
- Recent Advances in Cholinergic Imaging and Cognitive Decline—Revisiting the Cholinergic Hypothesis of Dementia (2018) (60)
- Striatal dopaminergic denervation and gait in healthy adults (2008) (60)
- Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders (2007) (59)
- Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease (2007) (59)
- Tolerance for light and sound of patients with persistent post-concussional symptoms 6 months after mild head injury (2004) (56)
- Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults. (2007) (56)
- Cerebellar Changes in Partial Seizures: Clinical Correlations of Quantitative SPECT and MRI Analysis (1998) (56)
- Coping styles, cortisol reactivity, and performance in a vigilance task of patients with persistent postconcussive symptoms after a mild head injury. (1992) (55)
- Age-associated leukoaraiosis and cortical cholinergic deafferentation (2009) (55)
- Clinical markers for identifying cholinergic deficits in Parkinson's disease (2015) (54)
- Striatal and Cortical β‐Amyloidopathy and Cognition in Parkinson's Disease (2016) (53)
- An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group. (2017) (53)
- Brain tumor and exposure to pesticides in humans: a review of the epidemiologic data (1995) (51)
- Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication (2015) (49)
- Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease (2019) (47)
- Source memory and frontal functioning in Parkinson’s disease (2009) (47)
- l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease (2012) (42)
- Olfactory loss and nigrostriatal dopaminergic denervation in the elderly (2010) (41)
- Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults (2011) (41)
- Association of COMT val158met and DRD2 G>T genetic polymorphisms with individual differences in motor learning and performance in female young adults. (2014) (38)
- Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography study (2018) (38)
- Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses (2017) (37)
- Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study. (2005) (36)
- Neuroimaging and clinical predictors of fatigue in Parkinson disease. (2016) (34)
- The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease (2019) (34)
- Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. (2012) (34)
- Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease (2020) (33)
- White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia (2006) (33)
- Serotonin, β‐amyloid, and cognition in Parkinson disease (2018) (32)
- In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease (2013) (32)
- Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV (2018) (32)
- Molecular Imaging of the Cholinergic System in Parkinson's Disease. (2018) (31)
- Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations (2021) (31)
- Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections. (2009) (31)
- The Role of Serotonin in Sleep Disordered Breathing Associated with Parkinson Disease: A Correlative [11C]DASB PET Imaging Study (2012) (30)
- Is normosmic Parkinson disease a unique clinical phenotype? (2016) (29)
- Multimodal dopaminergic and free-water imaging in Parkinson's disease. (2019) (28)
- Pitfalls in the measurement of plasma osmolality pertinent to research in vasopressin and water metabolism. (1992) (28)
- Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. (2017) (28)
- Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches (2022) (28)
- Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects. (2009) (27)
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. (2016) (27)
- Educational attainment and motor burden in Parkinson's disease (2015) (26)
- Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System (2019) (26)
- Vascular and dopaminergic contributors to mild parkinsonian signs in older adults (2018) (24)
- Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation (2016) (24)
- Influence of age and sex on 19 blood variables in healthy subjects. (1992) (24)
- The role of positron emission tomography imaging in movement disorders. (2003) (24)
- Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. (2019) (24)
- Orthostatic hypotension predicts motor decline in early Parkinson disease. (2016) (22)
- Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity. (2009) (21)
- Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. (2011) (21)
- Aging, Vestibular Function, and Balance: Proceedings of a National Institute on Aging/National Institute on Deafness and Other Communication Disorders Workshop. (2020) (20)
- 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET (2017) (20)
- The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease (2013) (19)
- A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma (1993) (19)
- Imaging Markers of Progression in Parkinson's Disease (2018) (19)
- Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs. (2020) (19)
- Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias (2017) (19)
- Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease (2019) (19)
- Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. (2019) (19)
- Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation (2016) (18)
- Task-dependent interactions between Dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease (2013) (17)
- Persistent neuropsychological deficits in cervical whiplash patients without direct headstrike. (1993) (17)
- Age-related striatal dopaminergic denervation and severity of a slip perturbation. (2011) (17)
- ()-α-[11C]Dihydro- tetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis (1999) (17)
- Cognitive correlates of brain MRI subcortical signal hyperintensities in non‐demented elderly (2006) (16)
- Treatment options for postural instability and gait difficulties in Parkinson’s disease (2019) (16)
- FDG-PET and molecular brain imaging in the movement disorders clinic (2012) (16)
- Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board (2018) (16)
- Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. (2018) (16)
- Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. (2012) (16)
- Rhinorrhea: A common nondopaminergic feature of Parkinson's disease (2011) (16)
- Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease (2021) (16)
- Heterogeneity of cholinergic denervation in Parkinson disease (2012) (15)
- Gender differences in cholinergic and dopaminergic deficits in Parkinson disease (2013) (15)
- Dopamine‐Related Genotypes and Physical Activity Change During an Intervention: The Lifestyle Interventions and Independence for Elders Study (2018) (14)
- Peripheral neuropathy is associated with more frequent falls in Parkinson's disease. (2018) (14)
- An update on brain imaging in parkinsonian dementia. (2012) (14)
- Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration. (2015) (14)
- Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline (2019) (14)
- Association between autonomic dysfunction and fatigue in Parkinson disease (2017) (13)
- Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. (2014) (13)
- Influence of Striatal Dopamine, Cerebral Small Vessel Disease, and Other Risk Factors on Age-Related Parkinsonian Motor Signs. (2019) (12)
- A Psychophysical Method for Assessing Visual and Acoustic Hyperesthesia in Patients with Mild Head Injury (1991) (12)
- Discussion of Research Priorities for Gait Disorders in Parkinson's Disease (2021) (12)
- Water metabolism and postconcussional symptoms 5 weeks after mild head injury. (1993) (12)
- Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT. (2008) (12)
- Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography (2020) (12)
- History of falls in Parkinson disease is associated with reduced cholinergic but not nigrostriatal dopaminergic activity (2009) (12)
- Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease. (2014) (11)
- Striatal Denervation Pattern Predicts Levodopa Effects on Sequence Learning in Parkinson's Disease (2013) (11)
- Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. (2016) (10)
- The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease: preliminary observations (2019) (9)
- Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment (2022) (9)
- Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views (2021) (7)
- Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging (2019) (7)
- α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders (2020) (7)
- Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease. (2017) (7)
- PET imaging of the vesicular acetylcholine transporter (2012) (7)
- Levels of trace elements in blood in healthy aging subjects. (1994) (7)
- Non-Dopaminergic Therapies (2018) (7)
- (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis. (1999) (7)
- Brief communication: effects of diagnostic irradiation during pregnancy on head circumference at birth. (1996) (6)
- Body-first versus brain-first biological subtyping of Parkinson's disease. (2020) (6)
- Resting state connectivity within the basal ganglia and gait speed in older adults with cerebral small vessel disease and locomotor risk factors (2020) (6)
- Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease. (2018) (6)
- A frontotemporal dementia-like syndrome mimicking postpartum depression detected by 18F fluorodeoxyglucose positron emission tomography. (2012) (6)
- Color discrimination errors associate with axial motor impairments in Parkinson's Disease (2017) (6)
- Fatigue in Parkinson’s Disease Associates with Lower Ambulatory Diastolic Blood Pressure (2019) (5)
- Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study (2022) (5)
- Author response. (2014) (5)
- Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography (2021) (5)
- Prior blood transfusions and Alzheimer's disease. (1994) (5)
- Effects of donepezil on motor function in patients with Alzheimer disease. (2004) (5)
- Effects of apprehension of lumbar punction procedure on salivary cortisol, plasma vasopressin and osmolality in man (1992) (5)
- Functional correlates of self-reported energy levels in the Health, Aging and Body Composition Study (2021) (4)
- Crossed cerebro-cellular diaschisis in a patients with melas with aphasia but without hemiparesis. (1998) (4)
- Dopamine-dependent functional connectivity in Parkinson disease (2014) (4)
- Mentally stimulating activities associate with better cognitive performance in Parkinson disease (2017) (4)
- Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis? (2012) (4)
- Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits (2022) (4)
- Catechol‐O‐methyltransferase (COMT) polymorphism predicts rapid gait speed changes in healthy older adults (2021) (3)
- Surface projection maps of cortical amyloid binding reveal canonical patterns in neurodegenerative dementias (2012) (3)
- Parkinson's Disease: What role do pedunculopontine nucleus cholinergic neurons play? (2014) (3)
- Association of Cardinal Motor Symptoms with Region-Specific Dopamine Transporter Activity in Mild to Moderate Parkinson's Disease. (2013) (3)
- Isolated lower extremity I-131 bone marrow uptake in a runner. (2001) (3)
- Single case study of brain FDG PET imaging in a patient with catatonia. (2013) (3)
- Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. (2016) (3)
- Hypercholinergic activity in LRRK2 Parkinson's disease (2018) (3)
- Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—[11C]MP4A PET study (2016) (3)
- Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. (2012) (2)
- Inverse relationship between plasma vasopressin and intracranial pressure. (1992) (2)
- New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders (2020) (2)
- Progression of regional cortical cholinergic denervation in Parkinson disease: a longitudinal acetycholinesterase 11C-PMP PET study (2018) (2)
- Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography. (2021) (2)
- Gait Speed Is Preserved in Oligosystem Compared to Multisystem Neurodegeneration in Parkinson Disease (P04.165) (2013) (2)
- Paget disease of the thumb. (1999) (2)
- Parkinson Dementia: PET Findings (2014) (2)
- Csf arginine-vasopressin decreases during dehydration in a patient with post-traumatic diabetes insipidus. (1990) (2)
- Clinical correlation of multivariate spatial covariance analysis of 18F-FEOBV VAChT PET in Parkinson disease (2016) (2)
- Feasibility and behavioral effects of prolonged static and dynamic standing as compared to sitting in older adults with type 2 diabetes mellitus (2019) (2)
- Impaired color perception is associated with more severe nigrostriatal denervation in Parkinson disease (2013) (2)
- Somatostatin Receptor Scintigraphy of a Patient with a Giant Invasive Prolactinoma (1999) (2)
- Progression of regional cortical cholinergic denervation in Parkinson's disease. (2022) (2)
- Apathy but not depression is associated with amyloidopathy in Parkinson disease at risk for dementia (2015) (2)
- 2014 SNMMI Highlights Lecture: Neuroscience. (2014) (2)
- Cortico‐striatal functional connectivity and cerebral small vessel disease: Contribution to mild Parkinsonian signs (2021) (1)
- PET cardiac sympathetic imaging with 11C-hydroxyephedrine in idiopathic Parkinson's disease (2011) (1)
- Comorbid cortical {beta}-amyloid plaques affect postural instability and gait disorder symptoms in Parkinson disease (2012) (1)
- Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson disease: Most versus less affected side (2007) (1)
- Ratings of activities of daily living are associated with cortical cholinergic but not with the degree of nigrostriatal dopaminergic activity in Parkinson disease (2009) (1)
- In Vivo Positron Emission Tomography of Extrastriatal Non-Dopaminergic Pathology in Parkinson Disease (2018) (1)
- Gallbladder bed photopenic halo on hepatobiliary scintigraphy: a sign of biliary leakage. (1999) (1)
- Odor identification is a more robust measure of forebrain cholinergic activity than odor memory/discrimination tests in Parkinson disease (2013) (1)
- Use of Nuclear Medicine Molecular Neuroimaging to Model Brain Molecular Connectivity (2020) (1)
- Cerebellar acetylcholinesterase activity and parkinsonian motor impairment (2008) (1)
- Emerging non-invasive therapeutic approaches targeting hypocholinergic neural systems in Parkinson’s disease (2022) (1)
- Vulnerabilities of Aging and Biological Effects of Physical Activity Provide New Clues for Interventions in Parkinson's Disease. (2020) (1)
- A constrained method for acetylcholinesterase density estimation with [11C]PMP and PET (2008) (1)
- Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. (2015) (1)
- Have we been overestimating fall rates in Parkinson's disease? (2017) (1)
- Parkinsonian Dementias: PET Findings (2020) (1)
- Elevated Systolic Blood Pressure Predicts Motor Outcomes in Parkinson’s Disease--A Retrospective Analysis of the CALM-PD Trial (S5.004) (2016) (1)
- Letter re: Incident parkinsonism in older adults without Parkinson disease (2017) (1)
- Decreased vestibular efficacy contributes to abnormal balance in Parkinson's disease (2022) (1)
- Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon? (2020) (1)
- Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study (2016) (1)
- Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach (2022) (1)
- Cholinergic forebrain density loss in Parkinson disease (2018) (1)
- Effects of an overnight fluid infusion on cognitive functions in preoperative patients. (1989) (1)
- Pesticides and brain tumour. (1994) (1)
- Hepatobiliary scintigraphy in an immunosuppressed patient with hepatocellular dysfunction and acute cholecystitis: diagnostic dilemmas posed by delayed gallbladder visualization. (1998) (1)
- Catechol‐O‐Methyltransferase Genotype, Frailty, and Gait Speed in a Biracial Cohort of Older Adults (2020) (1)
- Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal (2023) (1)
- Progression to Advanced Scores on the Hoehn and Yahr Scale in Parkinson Disease Is Not Explained by Degree of Dopaminergic Denervation (P06.084) (2013) (1)
- ELECTRONIC PLATFORM MEASURES OF BALANCE IMPAIRMENT IN PARKINSONIANS AND FIRST DEGREE RELATIVES. (2004) (1)
- Catechol-O-Methyltransferase Genotype, Frailty, and Gait Speed: The Cardiovascular Health Study (2020) (0)
- INTERRELATION OF IN VIVO STRUCTURAL AND MOLECULAR IMAGING MARKERS OF CHOLINERGIC SYSTEM DEGENERATION IN PD-RELATED COGNITIVE DECLINE (2018) (0)
- Bidirectional longitudinal changes in regional cerebral covariance of vesicular acetylcholine transporter binding in Parkinson disease: Evidence for dynamic regional cerebral compensatory mechanisms (S45.007) (2018) (0)
- Postural sway as a biomarker of dopaminergic denervation in patients with mild Parkinson's disease (2007) (0)
- Postural sensory efficacy and striatal dopaminergic innervation in normal older adults (2010) (0)
- Increased frontal lobe white matter lesion burden is associated with increased cortical and raphe nucleus serotonin transporter expression in normal elderly (2012) (0)
- Obesity Associates with Impaired Quality of Life in Parkinson Disease (P2.056) (2014) (0)
- Striatal and cortical amyloidopathy and cognitive functions in Parkinson disease at risk of dementia (2015) (0)
- Both cortical cholinergic denervation and cortical {beta}-amyloid plaques contribute to cognitive impairment in Parkinson disease (2012) (0)
- Feasibility of carbon-11-dihydrotetrabenazine ligand influx images in a principal component based analysis (2009) (0)
- alpha4beta2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease (2020) (0)
- Neurological Applications of Radiopharmaceuticals (2020) (0)
- Excessive GABAergic Activity in Striatal and Frontal Cortical Regions Rather Than Dopaminergic Functions Are Related to Daytime Sleepiness in Parkinson Disease (S13.008) (2016) (0)
- Decreased Vestibular Efficacy Contributes to Non-Tremor Motor Impairments in Parkinson Disease (P6.384) (2016) (0)
- Bradykinesia, Rigidity, and Postural Instability and Gait Difficulty Occur More Commonly in Men with Parkinson Disease Compared to Women Independent of Nigrostriatal Dopaminergic Denervation (P06.044) (2012) (0)
- In vivo assessment of multiple neurodegenerations and cognitive impairment in Parkinson disease (2014) (0)
- Reply to: “Letter on Discussion of Gait Research” (2022) (0)
- DOPAMINERGIC GENOTYPE AND RESILIENCE TO SMALL VESSEL DISEASE ASSOCIATIONS WITH SLOWER GAIT SPEED (2018) (0)
- Cardiovascular risk factors associate with cholinergic denervation in Parkinson disease (P2.152) (2015) (0)
- REM sleep behavior disorder is associated with cortical cholinergic deficit in Parkinson's disease without dementia (2010) (0)
- The Prevalence of Impaired Olfaction in Parkinson's Disease Is Higher Than Previously Estimated (P07.129) (2012) (0)
- AGE-ASSOCIATED DOPAMINERGIC INFLUENCES ON FOOT-TAPPING AND TEMPORAL GAIT PARAMETERS IN HEALTHY OLDER ADULTS (2008) (0)
- Festination and gait speed in Parkinson disease (2018) (0)
- Invited commentary on "Structural and functional imaging in parkinsonian syndromes". (2014) (0)
- Predictive models of postural control based on electronic force platform measures in patients with Parkinson's disease. (2005) (0)
- 021 USING NEUROCHEMICAL IMAGING TO UNDERSTAND GAIT AND MENTAL FUNCTION IN PARKINSON DISEASE (2010) (0)
- Vitamins, metals and routine bloodchemistry in normal aging: Results from a multiple cohort study ∗N. Bohnen, J. Jolles and C. Degenaar. Dept of Neuropsychology & Psychobiology; Limburg University; Box 616; 6200 MD Maastricht; The Netherlands (1990) (0)
- Author response. (2014) (0)
- Reader response: Odor identification as a biomarker of preclinical AD in older adults at risk (2018) (0)
- Peduncolopontine nucleus-thalamic acetylcholinesterase activity in Alzheimer and Parkinson disease (2011) (0)
- Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease (2023) (0)
- Thalamic GABAa Receptor Expression is Inversely Correlated with Axial Motor Impairments in Parkinson Disease (P6.082) (2015) (0)
- Cognitive Enhancers as a Means to Reduce Falls in Older Adults (2019) (0)
- 2015 SNMMI Highlights Lecture: Neurosciences. (2015) (0)
- Variability in foot-tapping as a new biomarker of nigrostriatal dopaminergic denervation in Parkinson's disease (2009) (0)
- P1.118 Relationship between olfactory dysfunction and Body Mass Index in patients with Parkinson disease (2009) (0)
- Presence and intensity of tremor reflects subcortical cholinergic but not nigrostriatal dopaminergic innervation changes in Parkinson disease (2010) (0)
- Cholinergic and dopaminergic PET imaging of gait in Parkinson disease (2010) (0)
- Automated Synthesis of 18F-BCPP-EF {2-tert-Butyl-4-Chloro-5-{6-[2-(2[18F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2H-Pyridazin-3-One for Imaging of Mitochondrial Complex 1 in Parkinson’s Disease (2022) (0)
- Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls. (2021) (0)
- Cognitive correlates of posterior cingulate hypometabolism in Parkinson disease (2008) (0)
- Molecular Imaging of Neurodegenerative Parkinsonism. (2021) (0)
- Reply: Cognition and olfaction in Parkinson's disease (2010) (0)
- Testicular I-131 6beta-iodomethyl-19-norcholesterol uptake in a patient with adrenogenital syndrome. (1999) (0)
- Brain Dynamics Underlying Preserved Cycling Ability in Patients With Parkinson’s Disease and Freezing of Gait (2022) (0)
- Bohnen, N and Grothe, M and Ray, NJ and Muller, M and Teipel, S (2018)Re- cent Advances in Cholinergic Imaging and Cognitive Decline—Revisiting the Cholinergic Hypothesis of Dementia. Current Geriatrics (2019) (0)
- Subtype definition of vascular parkinsonism. (2018) (0)
- More severe parkinsonism is associated with lower physical activity-related energy expenditure in PD (P7.289) (2015) (0)
- Dopaminergic Vulnerability and Motor Impairments in Older Adults: Need for Targeted Pharmacotherapy (2020) (0)
- Dopaminergic Signaling: Driver of Mobility Resilience and Moderator of Response to Pharmacotherapy (2020) (0)
- MRI for correlative imaging of the nigrostriatal dopaminergic system: A guide for nuclear medicine physicians (2013) (0)
- Automated production of [11C]butyrate for keto body PET imaging. (2023) (0)
- Striatal vesicular acetylcholine transporter expression and cognitive function in Parkinson disease (2014) (0)
- A multisystem model of vascular parkinsonism: Interaction between vascular and neurodegenerative mechanisms (2020) (0)
- Selective hyposmia and striatal monoaminergic vesicular binding binding in Parkinson disease (2008) (0)
- Heterogeneity of neurodegeneration in Parkinson disease: Variable degree of dopaminergic versus cholinergic denervation (2009) (0)
- Cognitive dysfunction in Parkinson’s disease Disturbances of cognition are frequent find- ings in Parkinson’s disease (PD) patients with point prevalence estimates of frank dementia (2012) (0)
- Dopamine overdose and motor sequence learning Title : Effect of dopaminergic medications on the time course of explicit motor sequence 1 learning in Parkinson ’ s disease (2009) (0)
- Diabetes Is Associated with Bradykinesia and Postural Instability and Gait Difficulty in Parkinson Disease Independent of Nigrostriatal Dopaminergic Denervation: A Case-Control Study (P07.125) (2012) (0)
- CORTISOL REACTIVITY AND COGNITIVE PERFORMANCE IN A CON~NUOUS MENTAL TASK PADDING * N. BOHNEN **, P. HOUX, N. NICOLSON, and J. JOLLES (2002) (0)
- Cortical and subcortical cholinergic innervation in normal aging (2010) (0)
- Prior Intra-operative Hypotension is not a Risk Factor for Development of Alzheimer’s Disease (1996) (0)
- Odor identification as a biomarker of neurodegeneration in the elderly (2018) (0)
- Posterior cortical hypometabolism precedes mixed subcortical-cortical metabolic changes in incident dementia in Parkinson disease (2008) (0)
- Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease (2018) (0)
- Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease. (2022) (0)
- Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's Disease (2022) (0)
- A resting-state diagnosis ? Dopamine-dependent functional connectivity in Parkinson (0)
- Cholinergic system correlates of postural control changes in Parkinson's disease freezers. (2023) (0)
- IC-P-178 COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER’S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER OF IN VIVO STRUCTURAL AND MOLECULAR IMAGING MARKERS OF CHOLINERGIC SYSTEMDEGENERATION IN PD-RELATED COGNITIVE (2018) (0)
- Persisting post concussional symptoms and water metabolism (1990) (0)
- Lower Education Status Associates With Axial Motor Burden In Parkinson Disease (P5.265) (2014) (0)
- No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson’s Disease (2022) (0)
- Cholinergic Integrity And Visual Hallucinations In Parkinson Disease (S18.004) (2014) (0)
- PL3.3 Selected oral abstract: Fall history is associated with severity of white matter changes but not striatal dopaminergic denervation (2008) (0)
- Cholinergic degeneration within a large scale neural network is a major driver of cognitive impairment in Parkinson's disease (2020) (0)
- Striatal dopaminergic correlates of the Montreal Cognitive Assessment test and the Mini Mental State Exam in Parkinson disease: A [11C]-DTBZ PET study (2012) (0)
- Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis (2022) (0)
- Regional brain cholinergic system changes in Parkinson disease with RBD: an 18F-FEOBV PET study (2019) (0)
- TWO AUTOCOVARIANCE-BASED MEASURES OF BALANCE IN PARKINSONIANS AND NORMAL CONTROLS. (2010) (0)
- ALZHEIMER DISEASE AND ANESTHETIC EXPOSURE. AUTHORS' REPLY (1994) (0)
- Cerebellar vermis vesicular acetylcholine transporter expression and parkinsonian motor impairment (2014) (0)
- Regional Serotonin Terminal Density in Aging Human Brain: A [11C]DASB Pet Study (2022) (0)
- INTERRELATION OF IN-VIVO STRUCTURAL AND MOLECULAR IMAGING MARKERS OF CHOLINERGIC SYSTEM DEGENERATION IN PD-RELATED COGNITIVE DECLINE (2018) (0)
- Indexes to volume 58 (2005) (0)
- A placebo-controlled trial shows no effect of a vasopressin analogue (DGAVP) on subjective and cognitive recovery immediately after mild head injury (1992) (0)
- GAIT SLOWING AMONG FRAIL OLDER ADULTS: IS HIGHER DOPAMINERGIC SIGNALING PROTECTIVE? (2019) (0)
- 4. A placebo-controlled trial shows no effect of a vasopressin analogue (DGAVP) on subjective and cognitive recovery immediately after mild head injury (1992) (0)
- P2.009 Aging-related striatal dopaminergic denervation, balance and gait in healthy adults (2008) (0)
- Diabetes Is Associated with Increased Central Neurotoxicity in Parkinson Disease: A Case-Control Study (P06.098) (2013) (0)
- Gender Differences in Dopaminergic and Cholinergic Integrity in Parkinson Disease (P06.080) (2013) (0)
- In reply (1994) (0)
- Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls (2020) (0)
- Pattern of cardiac s ympathetic Denervation in idiopathic Parkinson Disease s tudied with (2012) (0)
- Interaction of Striatal Dopaminergic and Cholinergic Activity in Parkinson Disease: A Multimodal Imaging Study Based on 11C-DTBZ and 18F- FEOBV PET Combined with Diffusion Tensor Imaging (2020) (0)
- Regional covariance of brain cholinergic terminal changes in Parkinson disease: an 18F-FEOBV PET study (2016) (0)
- Dopaminergic and Cholinergic Brain Activity and Performance on MMSE and MoCA in Parkinson's Disease (P03.127) (2012) (0)
- Interval Changes Of Forebrain-Cortical Versus Brainstem-Thalamic Cholinergic Integrity In Parkinson Disease Progression (P2.007) (2014) (0)
- Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's disease. (2022) (0)
- 050 ASSOCIATION BETWEEN BRAIN WHITE MATTER TRACT INTEGRITY AND CLINICAL MEASURES OF FALL RISK IN OLDER ADULTS (2010) (0)
- Dopaminergic and cholinergic correlates of rhythmic foot oscillation control in Parkinson disease (2010) (0)
- Decreased Vestibular Efficacy Contributes To Balance Impairment in Parkinson Disease (PD4.009) (2012) (0)
- Twelfth annual symposia on etiology, pathogenesis, and treatment of parkinson's disease and etiology, pathogenesis, and treatment of Huntington's disease (1998) (0)
- Cardiac post-ganglionic sympathetic denervation correlates selectively with REM sleep behavior disorder symptoms in Parkinson disease. (2015) (0)
- Neurovegetative Complaints Questionnaire (2016) (0)
- Associations between a measure of brain network metabolic activity and non-motor measures of Parkinson's disease (2009) (0)
- Imaging of sleep disorders in pre-Parkinsonian syndromes (2022) (0)
- Shape analysis method can be used for limited non-invasive estimation of striatal and cerebellar [11C]-PMP k3 hydrolysis rates (2011) (0)
- Imaging Cognitive Dysfunction in Parkinson's Disease (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nicolaas I.l.j. Bohnen?
Nicolaas I.l.j. Bohnen is affiliated with the following schools:
